YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Triaminic Vapor Patch
Triaminic Vapor Patch Removed from Market
On June 19, 2006 Novartis AG, the manufacturer of the Triaminic Vapor Patches recalled the patches, after a child experienced a seizure after chewing on the cough-suppressing vapor patch. The current recall includes the mentholated cherry and menthol scented versions. Novartis has instructed all individuals who currently have the patch to either discard them right away or return them to the establishment they were bought, for a full refund.Triaminic Vapor Patches is made up of menthol, camphor, and eucalyptus oil. Both of these substances are designed to be applied to the chest or throat of children as young as 2 to allow vapors to reach the nose and mouth. Each patch contains approximately 4.7% of camphor and 2.6% of menthol. Triaminic Vapor Patches are used to temporarily relieve coughs due to minor throat and bronchial irritations.
Side Effects
If Camphor or eucalyptus oil is eaten an individual can encounter a burning feeling in the mouth, nausea, headaches, vomiting or seizure. Other inhalation ailments can consist of blistering, scarring, bruising, hyperactivity and depigmentation, the loss of pigment from the skin, mucous membranes, hair, or retina of the eye.
Canadian Warning
On June 5, 2006, Health Canada warned consumers not to use Triaminic Vapour Patches due to potential side effects. Triaminic Vapor Patches was introduced to the market in 2000. Since then an estimated 50 million patches have been sold. Triaminic Vapor Patches can be purchased at retail stores or pharmacies.
Free Lawsuit Case Consultation
If your child accidently ingested a Triaminic Vapor Patch and suffered a seizure or any other injury, please fill out the form at the right for a free case evaluation by a qualified defective medical device attorney.
Triaminic Vapor PatchRSS Feed
Triaminic recalls its patch after ingestions
Jun 21, 2006 | Philadelphia Inquirer
Thousands of Triaminic Vapor Patches, used to treat children with coughs and colds, are being voluntarily recalled after several bad reactions, including a seizure. The over-the-counter cough suppressant works through inhaled vapors to loosen up congestion. More than 50 million patches have been sold in the United States since they first came on the market in 2000, said Julie Masow, a Novartis Consumer Health spokeswoman. There have been eight adverse events with the patch, all involving...
Seizure leads to recall of vapor patches
Jun 20, 2006 | AP
A child suffered a seizure after chewing on a cough-suppressing vapor patch, leading Novartis AG to recall the patches Monday. The Swiss drug company warned consumers to stop using its Triaminic Vapor Patches immediately. The recalled patches include both the mentholated cherry and menthol scented versions sold by Novartis Consumer Health. They should be discarded or returned to the place of purchase for a full refund, the company said. The patches contain camphor, eucalyptus oil and menthol...
Novartis recalls cough-suppressant Triaminic Vapor Patch due to health risks
Jun 20, 2006 | AFX
Novartis AG said it has started to recall its Triaminic Vapor Patch cough-suppressant because of potential health threat to children who might remove it and chew on the patch. Vapor Patch is widely available in the US and sold over the counter. The US Food and Drug Administration has registered the recall, Novartis said.
Novartis Consumer Health Conducts Nationwide Voluntary Recall of Triaminic Vapor Patch Product in U.S.
Jun 19, 2006 | PR Newswire
Novartis Consumer Health announced today it is conducting a nationwide voluntary recall of all Vapor Patch product marketed under the Triaminic brand due to the serious adverse health effects that could result if the product is ingested by the child removing the patch and chewing on it. Consumers who have Triaminic Vapor Patches should stop using them immediately. There have been multiple reported complaints received, including seizures. Novartis Consumer Health's number one priority is the...
Novartis recalls Triaminic Vapor Patch in U.S.; follows move in Canada
Jun 19, 2006 | Canadian Press
Novartis AG has recalled cough-suppressing Triaminic Vapor Patches in the United States, about three weeks after Health Canada warned that a Canadian child who chewed on a patch suffered a seizure. The Swiss drug company told consumers to stop using its Triaminic Vapor Patches immediately. The recalled patches include both the mentholated cherry and menthol scented versions sold by Novartis Consumer Health. They should be discarded or returned to the place of purchase for a full refund, the...
Defective Medical Devices
Quick Facts
Triaminic Vapor Patch Reference Guide
Manufacturer
Novartis AG
Date Approved
2000
Approved Uses
Cough suppressant
Status
6/5/2006 Health Canada warning
6/19/2006 FDA warning
6/19/2006 Novartis issues recall Side Effects
Burning in the mouth
Nausea
Headaches
Vomiting
Seizure
Blistering
Scarring
Bruising
Hyperactivity
Depigmentation
Related Topics
Defective Medical Devices
Novartis AG
Date Approved
2000
Approved Uses
Cough suppressant
Status
6/5/2006 Health Canada warning
6/19/2006 FDA warning
6/19/2006 Novartis issues recall Side Effects
Burning in the mouth
Nausea
Headaches
Vomiting
Seizure
Blistering
Scarring
Bruising
Hyperactivity
Depigmentation
Related Topics
Defective Medical Devices
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS